Skip to main content
. Author manuscript; available in PMC: 2011 Jul 6.
Published in final edited form as: Leukemia. 2010 Jun 24;24(9):1545–1554. doi: 10.1038/leu.2010.143

Table 1.

Comparison of the different properties of LSCs between chronic-phase and blast-crisis CML.

Chronic-phase CML Blast-crisis CML
LSCs BCR-ABL transformed HSCs BCR-ABL transformed GMPs
Human LSC markers CD34+CD38−CD90+Lin− CD34+CD38+Lin−
Mouse LSC markers Lin−c-Kit+Sca-1+ Lin−c-Kit+Sca-1−FcγR+
Activation of Wnt/ β-catenin Yes Yes
Other oncogenic mutations Unclear Yes
Treatment Imatinib Chemotherapy or BMT